Skip to main content
S

SciBac

SciBac develops biotherapeutics that target antibiotic-resistant infections by utilizing advanced microbial engineering techniques. The company aims to provide effective treatment options for patients suffering from diseases caused by antibiotic-resistant bacteria.

Traction 3/10
HQ unknown
Founded 20152200+ followers
  • Biotechnology
Updated 23 months ago

Funding

Raised to date

$286.5KRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

1 founder

Anthony Cann

Co Founder

Product

Features

  • SciBac develops biotherapeutics that target antibiotic-resistant infections by utilizing advanced microbial engineering techniques. The company aims to provide effective treatment options for patients suffering from diseases caused by antibiotic-resistant bacteria.
This profile is AI-generated and may contain inaccuracies.